Full Text Article

Phyllanthus Muellerianus, (Kuntze) Eccell. Review of the Ethnomedical Uses, Phytochemistry and Pharmacological Activities

Received Date: April 12, 2023 Accepted Date: May 12, 2023 Published Date: May 15, 2023

doi: 10.17303/jmph.2023.2.102

Citation: Martha Nneoma Ofokansi, Peter Achunike Akah, Juliet Ogochukwu Omewu (2023) Phyllanthus Muellerianus, (Kuntze) Eccell.: Review of the Ethnomedical Uses, Phytochemistry and Pharmacological Activities. J Med Plant Herbs 2: 1-12

Herbal products have been used over the decades in the management and treatment of some health challenges and diseased conditions. Phyllanthus muellerianus (Kuntze) Excell (Phyllanthaceae), a popular member of genus Phyllanthus is native to Africa and most tropical and subtropical countries. The readily availability and cultural heritage of this plant across generations may account for its wide use as traditional medicine. The plant is reported to possess many beneficial pharmacological activities such as anti-inflammatory, anti-nociceptive, antibacterial, antioxidant, anticancer, hypocholestrolemic and immunomodulatory activities. The purpose of this review is to provide updated and comprehensive literature data on the traditional uses, phytochemistry and pharmacological activities of Phyllanthus muellerianus so as to expose its numerous therapeutic potentials and possible future research opportunities.

Keywords: Phyllanthus Muellerianus; Folkloric uses; Pharmacological activities; Phytochemistry

The Phyllanthaceae family is the second-most species-rich segregate from Euphorbiaceae sensu lato that is recognized [1]. Currently, it is comprised of 2000 species [2,3]. The relationships and circumscriptions of the genera has been the focus of extensive discussion. Revised classification of different tribes of Phyllanthaceae [4,5-7] was done after the previous study on the phylogenetic which elucidated their numerous structures [5,8,9]. The genus Phyllanthus muellerianus (Kuntze) Exell (Euphobiaceae) is widely distributed in the tropical region of West Africa. It is a small plant that grows throughout the season with canopy-forming leaves. It has fruits that are copious panicles of small red, shining berries that eventually turn black.

The relationship between genus Phyllanthus L. and other members of pantropical family Phyllanthaceae was confirmed by the similarities in their nuclear DNA sequenced data collected from previous studies [8-10]..Species in this genus vary widely, and are distributed in southern Nigeria and the tropical regions of the world [8,11]. They are monoecious plant with simple alternate leaves and very small diclinous flowers that cluster in cup-shaped structures. The fruit is a lobed-capsule extending from the cup and commonly the long stalk pendant. Phyllantus muellerianus is a woody climber, up to 12 m tall and sometimes arborescent. It has spines, with copious inflorescences of minute greenish flowers, and small berry-like red fruit [12,13]. The purpose of this review is to provide comprehensive information on the phytochemistry, traditional uses and pharmacological activities of Phyllanthus muellerianus in order to explore its therapeutic potentials, highlight the lacunae in the present knowledge and also evaluate future research opportunities.

Chemical Constituents

Detailed phytochemical properties of P. muellerianus are necessary to understand its pharmacological activities, mechanisms of action and also for quality control purposes. Chemical investigations of this specie have led to the identification and isolation of several groups of chemical constituents. More than 510 compounds were isolated from Phyllanthus [14] and comprised mostly of triterpenoids [15], flavones [16], tannins [17,18] and lignans [19] Basic phytochemical groups have been isolated and reported from muellerianus species (Table 1). These isolated compounds exhibit various functions and are considered to exert different pharmacological activities. The proximate analysis of P.muellerianus leaf [20] indicated that it is enriched with fibre, fat, proteins, carbohydrates, ash and moisture contents making the leaf a source of food supplement in developing countries. The high fibre content makes it a good hypocholesterolaemic agent for people with cholesterol related problems [21]. Flavonoids have been reported to be synthesized by plants in response to microbial infection and have been shown to have antibacterial activities [22-24]. The terpenoids are established as anti-inflamatory agent as well as analgesic agent [25,26]. Gallate is an antioxidant used in fatty food preservation [27]. Other properties conferred on this plant by the presence of these compounds include sweetening property, immune modulation, regulation of cell proliferation, neutral sterol metabolism and energy boosting property [20].

Ethnopharmacological Uses

Available literatures have provided information on the traditional uses of P. muellerianus in the treatment of different ailments in different parts of the world. The most widespread uses are in wound healing, menstrual disorder, dysentry and pain as well as kidney disorders. It has also been used against skin infections, intestinal worms and eye infections. Table 2 presents various documented ethnobotanical uses of P. muellerianus in different parts of the world.

In Guinea, the leaves are boiled with palm fruits and administered to women undergoing labor. The root is cooked with maize meal in Ghana for treating chronic dysentery and in Togo, Côte d'Ivoire, and Zambia, both the roots and leaves are boiled for treatment of eruptive fever in children [37]. The fresh juice of the plant is used in southern part of Nigeria and Sierra Leone to treat skin and eye infections [37,38], as well as bronchitis, relieving urethral discharge and wound healing [37].

Pharmacological Activities

P. muellerianus posseses numerous pharmacological properties. It has complex chemistry with molecules of therapeutic importance. Extracts of the leaf of P. muellerianus are nontoxic to tested living organs [45,47]. The neuro- and hepatoprotective potentials of the leaf extract have been reported [48,49]. Several pharmacological studies have been carried out to investigate its acclaimed uses in wound healing, management of pain and inflammation; antioxidant, immunomodulatory and other pharmacological properties.

The information on this species was collected via electrionic search engines (using Pubmed, SciFinder, Google Scholar and Web of Science) and articles published in peer-reviewed journals. Some of the pharmacological investigations on P. muellarianus are summarized thus;

Antimicrobial

The leaf and stem bark of P. muellerianus have demonstrated antimicrobial activity against different pathogenic strains [32,50]. The methanol and ethyl acetate stem bark extracts have been reported to exhibit potent antibacterial activity [41,51]. The antimicrobial activity of the stem bark essential oil against Clostridium sporogenes and Streptococcus pyogenes has been documented [38]. The effects of the aqueous leaf extracts against S. aureus, S. pyogenes, P. aeruginosa, E. coli and C. albicans was attributed to the geraniin content [26]. Two studies [52,53] reported that the methanol leaf extract and chromatographic fractions exerted antimicrobial action against P. aeruginosa, P. mirabilis and E. faecalis while synergestic effect against P. aeruginosa was observed through combination of ciprofloxacin and the extract.

Klebsiella granulomatis, a human pathogenic bacterium was inhibited by the volatile oil from the leaf [49]. Other human pathogenic bacteria such as Escherichia coli, Staphylococcus aureas, and Salmonella typhi [54] and other bacteria like Bacillus cereus and Klebsiella pneumonia [55] have been reported to be sensitive to the leaf extracts.

Anti-inflamatory and Anti-nociceptive

The aqueous leaf extract of P. muellerianus and the major isolate, geraniin have demonstrated anti-inflammatory activity [26[. The essential oil from the leaf was reported to exhibit both anti-inflammatory and anti-nociceptive activities by suppressing the production of pro-inflammatory mediators and depressing the central nociceptors respectively. A significant anti-nociceptive activity of the aqueous extract of the aerial parts of Phyllanthus muellerianus against chemical (acetic acid and formalin)-induced nociception in mice is also documented [56].

Antioxidant

Evidence has been provided suggesting that P. muellerianus could stimulate the production of super oxide dismutase, catalase and ascorbate peroxidase which are antioxidant coding genes acting against reactive oxygen species causing delay in wound healing [39]. Similar in-vitro antioxidant activity of P.muellerianus has been reported by other workers [20,28,57]. Compared to the methanol extract, the aqueous leaf extract contains high hydroxyl radical scavenging and free radical scavenging (DPPH) antioxidant activity, while ferric reducing antioxidant was more in the methanol extract. The hydromethanolic extract of P.muellerianus appeared to possess a high antioxidant activity compared to other Phyllanthus species [58]. The antioxidant property of the plants was attributed to the presence of flavonoids acting as free radical scavenger and also aids in inhibition of lipid peroxidation hence relaxation of vascular system thereby preventing artherosclerosis [59]. Previous study [38] attributed the antioxidant activity to its geraniin constituent. The geranin is a strong antioxidant and it is used in treatment of chronic wound [56]. It has been suggested [60-62] that P. muellerianus would be of great health benefits due to its antioxidant properties.

Antianemic

Aqueous root extract of P. muellerianus was demonstrated efficacious against anemia in rats, exhibiting a dose dependent effect [63,64]. A study [65] also revealed that the root extract could be used for recovery of damaged blood tissue in fish because of its haematopoietic effects. The leucopoietic effect of the methanol leaf extract of the plant in immunocompromised rats is also reported [66].

Hypocholestrolemic and cardioprotective effects

Reduction and normalization of the glucose level in streptozotocin induced diabetic rat by aqueous leaf extract of P. muellerianus has been reported [67]. The study also reported the normalization of total cholesterol levels, LDL-cholesterol and triglycerides with significant increase in HDL-cholesterol. P. muellerianus has been used to treat atrial fibrillation due to congenital heart defects because of the presence of cardiac glycosides [68]. Saponins present in this plant expressed several benefits such as; inhibition of growth of cancerous cells and as hypocholesterolemic agent [69].

Immunomodulatory

The methanol extract and ethylacetate fraction of P. muellerianus exhibited significant effects on leucopoiesis in cyclophosphamide-induced immunosuppressed rats [66]. There was an inhibition and stimulation of delayed type-hypersensitivity reaction against sheep red blood cells in mice with the ethyl acetate fraction evoking the highest inhibition and stimulation at highest and lowest dose respectively [66]. Thus, it is suggested that P. muellerianus may be useful as an immunosuppressive agent at high doses for unwanted immune (eg allergic and inflammatory reactions) reactions and immune booster at low doses in the cases of impaired immunity.

Neuropharmacological

A recent study [70] has shown that the methanol leaf extract of P. muellerianus elicited sedative, anticovulsants and anxiolytic activities. According to the report, the ethyl acetate fraction produced anxiolytic and anticonvulsant activities but devoid of sedative effect as is the case with many currently available anxiolytic and anticonvulsant agents [70].

Antimalarial

In vitro antiplasmodial studies [45] has shown that the ethanol leaf extracts of P. muellerianus exhibited potent inhibitory activity against chloroquine-resistant FcB1 strain of Plasmodium falciparum. The result showed a high selectivity for the parasite hence, its potential benefit in the treatment of resistant falciparum malaria.

Anticancer activity

The anti-proliferative and pro-apoptotic activities of P. muellerianus has been illustrated [57] and the study indicated that the plants expressed anti-proliferative property against human prostate cancer PC-3 cells through modulation of the calcium channels making it a good therapeutic agent for the treatment of prostate cancer.

The healing properties of Phyllanthus muellerianus have been used for decades in traditional medicine. Current studies have illustrated different pharmacological activities which are also in line with their ethnopharmacological uses. The numerous studies conducted on Phyllanthus muellerianus, portray a plant with a lot of promising prospects. Extensive research has been done on the antimicrobial, anti-inflammatory as well as the antioxidant activity but there are other less putative effects especially in cancer treatment that have not been explored, hence there is need for more studies with a view of uncovering its therapeutic benefits.

The authors declare no conflict of interest

  1. Angiosperm Phylogeny Group (2009) An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III. Bot J Linnean Soc 161: 105-21.
  2. Govaerts R, Frodin DG. Radcliffe-Smith A. Carter S (2000) World Checklist and Bibliography of Euphorbiaceae (with Pandaceae). Royal Botanic Gardens, Kew.
  3. Hoffmann P, Kathriarachchi H, Wurdack KJ (2006) A phylogenetic classification of Phyllanthaceae (Malpighiales; Euphorbiaceaesensulato). Kew Bulletin 37-53.
  4. van Welzen PC, Strijk JS, van Konijnenburg-van Cittert, JH et al. (2014) Dated phylogenies of the sister genera Macaranga and Mallotus (Euphorbiaceae): congruence in historical biogeographic patterns? PLoS One 9: p.e85713.
  5. Vorontsova MS, Hoffmann P, Kathriarachchi H et al. (2007) Andrachne cuneifolia (Phyllanthaceae; Euphorbiaceaesl) is a Phyllanthus. Botanical J Linnean Soc 155: 519-25.
  6. Ralimanana H, Hoffmann P (2011) Taxonomic revision of Phyllanthus (Phyllanthaceae) in Madagascar and the Comoro Islands I: Synopsis and subgenera Isocladus, Betsileani, Kirganelia and Tenellanthus. Kew Bulletin 66: 331-65.
  7. Ralimanana H, Hoffmann P, Rajeriarison C (2013) Taxonomic revision of Phyllanthus (Phyllanthaceae) in Madagascar and the Comoro Islands III: Subgenera Swartziani, Afroswartziani and Emblica. Kew Bulletin 68: 535-58.
  8. Kathriarachchi H, Samuel R, Hoffmann P et al. (2006) Phylogenetics of tribe Phyllantheae (Phyllanthaceae; Euphorbiaceaesensulato) based on nrITS and plastid matK DNA sequence data. Am J Botany 93: 637-55.
  9. Samuel R, Kathriarachchi H, Hoffmann P et al. (2005) Molecular phylogenetics of Phyllanthaceae: evidence from plastid matK and nuclear PHYC sequences. Am J Botany 92: 132-41.
  10. Wurdack KJ, Hoffmann P, Samuel R et al. (2004) Molecular phylogenetic analysis of Phyllanthaceae (Phyllanthoideae pro parte, Euphorbiaceaesensulato) using plastid rbcL DNA sequences. Am J Botany 91: 1882-900.
  11. Unander DW, Webster GL, Blumberg BS (1991) Uses and bioassays in Phyllanthus (Euphorbiaceae): a compilation: II. The subgenus Phyllanthus. J Ethnopharmacol 34: 97-133
  12. Hutchinson J, Dalziel JM (1937) Tropical African Plants: XV. Bulletin of Miscellaneous Information (Royal Botanic Gardens, Kew) 1: 54-63.
  13. Burkill HM (1994) The useful plants of west tropical Africa. Volume 2: Families EI (Edn 2). Royal Botanic Gardens, Kew, Richmond, United Kingdom
  14. Mao X, Wu LF, Guo HL et al (2016) The genus Phyllanthus: an ethnopharmacological, phytochemical, and pharmacological review. Evid-Based Compl Altern Med. 2016; ID 7584952A
  15. Adesida GA, Girgis P, Taylor DAH (1972) Friedelin derivatives from Phyllanthus muellerianus. Phytochemistry 11: 481-8
  16. Chauhan JS, Sultan M, Srivastava SK (1977) Two new glycoflavones from the roots of Phyllanthus niruri. Planta Medica 32: 217-22
  17. Foo LY (1993) Amariin, a di-dehydrohexahydroxydiphenoyl hydrolysable tannin from Phyllanthus amarus. Phytochemistry 33: 487-91.
  18. Foo LY (1993) Amarulone, a novel cyclic hydrolysable tannin from Phyllanthus amarus. Natur Prod Letters 3: 45-52.
  19. Geethangili M. Ding T (2018) A Review of the Phytochemistry and Pharmacology of Phyllanthus urinaria L. Frontiers Pharmacol 9: 1109.
  20. Olalekan OJ. Apenah MO, Ogunbela AA et al (2020) Evaluation of the phytochemical, antioxidant and nutritional properties of Phyllanthus muellerianus leaves. J Res Forestry, Wildlife Environ 12: 142-9.
  21. Peter TO, Tolulope AO (2015) Proximate analysis and chemical composition of Cortinarius species. Eur J Adv Res Biol Life Sci 3: 1-9.
  22. Kujumgiev A, Tsvetkova I, Serkedjieva Y et al. (1999) Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmaco 64: 235-40.
  23. Górniak I, Bartoszewski R. Króliczewski J (2019) Comprehensive review of antimicrobial activities of plant flavonoids. Phytochem Rev 18: 241-72.
  24. Pietta PG (2000) Flavonoids as antioxidants. J Natu Prod 63: 1035-42.
  25. Ogunwande IA, Avoseh ON, Igile DO et al. (2019) Chemical constituents, anti-nociceptive and anti-inflammatory activities of essential oil of Phyllanthus muellerianus. Natur Prod Commun 14: 1934578X19846356.
  26. Boakye YD, Agyare C, Abotsi WKM et al. (2016) Anti-inflammatory activity of aqueous leaf extract of Phyllanthus muellerianus (Kuntze) Exell. and its major constituent, geraniin. J Ethnopharmacol 187: 17-27.
  27. Bekeh AF, Olatunji AE, Sandra O (2016) Influence of Phyllanthus muellerianus aqueous leaves extract on haematological picture of African catfish (Clarias gariepinus). Culture 15:17.
  28. Agyare C, Asase A, Lechtenberg M et al (2009) An ethnopharmacological survey and in vitro confirmation of ethnopharmacological use of medicinal plants used for wound healing in Bosomtwi-Atwima-Kwanwoma area, Ghana. J Ethnopharmacol 125: 393-403.
  29. Cesari I, Grisoli P, Paolillo M et al. (2015) Isolation and characterization of the alkaloid Nitidine responsible for the traditional use of Phyllanthus muellerianus (Kuntze) Excell stem bark against bacterial infections. J Pharmaceu Biomed Analy 105: 115-20.
  30. Saleem M, Nazir M, Akhtar N et al. (2009) New phthalates from Phyllanthus muellerianus (Euphorbiaceae). J Asian Natur Prod Res 11: 974-7.
  31. Burkill HM (2000) The Useful Plants of West Tropical Africa, Families SZ Addenda. Royal Botanic Gardens, Kew, Richmond, United Kingdom 5: 686.
  32. Doughari JH, Sunday D (2-8) Antibacterial Activity of Phyllanthus muellerianus. Pharmaceu Biol 46: 400-5.
  33. Agyare C, Lechtenberg M, Deters A et al. (2011) Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: Geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts. Phytomedicine 18: 617-24.
  34. Brusotti G, Cesari I, Gilardoni G et al. (2012) Chemical composition and antimicrobial activity of Phyllanthus muellerianus (Kuntze) Excel essential oil. J Ethnopharmacol 142: 657-62.
  35. Ndjonka D, Bergmann B, Agyare C et al. (2012) In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum. Parasitol Res 111: 827-34.
  36. Ofokansi MN, Ugwah-Oguejiofor CJ. Ihim S, Okoli CO Akah PA (2021) Neuropharmacological evaluation of the methanol leaf extract of Phyllanthus muellerianus (Kuntze) Exell and its ethyl acetate fraction in mice. Trop J Pharmaceu Res 20: 1463-72.
  37. Fowler DG (2006) Traditional fever remedies: a list of Zambian plants. Kirkia 18: 35-48
  38. Boakye YD, Agyare C, Hensel A (2016) Anti-infective properties and time-kill kinetics of Phyllanthus muellerianus and its major constituent, geraniin. Med. Chem 6: 95-104.
  39. Boakye YD, Agyare C, Ayande GP et al (2018) Assessment of wound-healing properties of medicinal plants: The case of Phyllanthus muellerianus. Frontiers Pharmacol 9: 945.
  40. Arbonnier M (2004) Trees, shrubs and lianas of West African dry zones. Trees, Shrubs and Lianas of West African Dry Zones pp.1-574.
  41. Asante-Kwatia E, Yeboah Mensah A, Frimpong Baidoo M (2020) Analgesic and anti-inflammatory effect of Ghanaian medicinal plants. Medicinal plants-use in prevention and treatment of diseases.
  42. Idris-Usman MS, John-Africa LB, Akuodor GC et al (2010) Antinociceptive and antipyretic properties of the pharmaceutical herbal preparation, Radix bupleuri in rats. J Medic Plants Res 4: 659-63.
  43. Neuwinger HD (2000) African traditional medicine: a dictionary of plant use and applications. With supplement: search system for diseases. Medpharm Scientific, Stuttgart, Germany 589.
  44. Das S, Das S, De B (2012) In vitro inhibition of key enzymes related to diabetes by the aqueous extracts of some fruits of West Bengal, India. Curr Nut Food Sci 8: 19-24.
  45. Zirihi GN, Mambu L, Guédé-Guina F et al. (2005) In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria. J Ethnopharmacol 98: 281-5.
  46. Chopra RN. Nayar SL, Chopra IC (1986) Glossary of Indian Medicinal Plants (Including Supplement). New Delhi: CSIR publications 235-86.
  47. Okeniyi JO. Loto CA, Popoola AP (2014) Electrochemical performance of Phyllanthus muellerianus on the corrosion of concrete steel-reinforcement in industrial/microbial simulating-environment. Portugaliae Electrochimica Acta 32: 199-211.
  48. Ibitoye OB, Aliyu NO, Ajiboye TO (2020) Protective Influence of Phyllanthus muellarianus on Ciprofloxacin-Induced Neurotoxicity in Male Rats. J Dietary Suppl 17: 321-35.
  49. Ajiboye TO, Ahmad FM, Daisi AO et al (2017) Hepatoprotective potential of Phyllanthus muellarianus leaf extract: studies on hepatic, oxidative stress and inflammatory biomarkers. Pharmaceu Biol 55:1662-70.
  50. Katsayal UA, Lamal RS (2009) Preliminary phytochemical and antibacterial screening of the ethanolic stem bark extract of Phyllanthus muellerianus. Nig J Pharmaceu Sci 8: 121-5.
  51. Assob JC, Kamga HL, Nsagha DS et al. (2011) Antimicrobial and toxicological activities of five medicinal plant species from Cameroon Traditional Medicine. BMC Compl Altern Med 11: 1-11
  52. Ofokansi KC, Attama AA, Uzor PF, Ovri MO (2013) Evaluation of the combined antimicrobial activity of the leaf extract of Phyllantus muellerianus with ciprofloxacin. J Pharm Technol Drug Res 2: 16.
  53. Akharaiyi FC, Dina AO (2018) Antimicrobial activities, antioxidant and phytochemical analysis of methanol and aqueous leaf extract of Phyllathus muellerianus (KUNTZ) Exell. Intern J Pharm Res Technol 8: 29-38.
  54. Ogbuanu CC, Amujiogu SN. Ude CM (2020) Antimicrobial activity of a plant anthocyanine against some human pathogens. Iintern J Engr Sci Math 9: 181-8.
  55. Bamisaye FA, Oloyede OB, Yakubu MT (2015) In vitro antibacterial activity of the aqueous extract of Phyllanthus muellerianus leaves against some selected organisms. Biosc Res Today’s World 1: 67-71.
  56. Boakye-Gyasi E, Kasanga EA, Biney RP et al. (2016) Anti-nociceptive effects of geraniin and an aqueous extract of the aerial parts of Phyllanthus muellerianus (Kuntze) Exell. in murine models of chemical nociception. Iranian J Pharmaceu Sci 12: 17-30.
  57. Deeh PBD, Arumugam M, Alagarsamy K et al. (2022) Phyllanthus muellerianus and Ficus exasperata exhibit anti-proliferative and pro-apoptotic activities in human prostate cancer PC-3 cells by modulating calcium influx and activating caspases. Biologia 77: 1981-94.
  58. Mwangu-Kabi ON, Nakweti RK. Ndiku SL. Antiplasmodial and antioxidant activities of Phyllanthus species and associated medicinal plants from Kenge in the Democratic Republic of Congo (DRC). Eur J Biol Biotechnol 1.
  59. Rahman R, Alias N, Leow ATC et al. (2015) Antilipase and antioxidant activity of Phyllanthus niruri methanolic extract. Aust J Basic Applied Sci 9: 133-6.
  60. Ademoye MA, Lajide L, Owolabi BJ (2018) Phytochemical and antioxidants screening of Chrysophyllum albidum, Mezoneuronbenthamianum, Phyllanthus muellerianus and Acalypha fimbriata. Intern J Sci 7: 8-18.
  61. Chiribagula VB, Bakari AS, Ndjolo PO et al. (2020) Phytochemical screening and antioxidant activity of methanolic extracts of 53 antimalarial plants from Bagira in Eastern DR Congo. GSC Biol Pharmaceu Sci 12: 99-118.
  62. Coolborn AF, Olabanjo DA, Chinedu OA (2019) Antimicrobial activities, phytochemical and antioxidant analyses of Phyllanthus mullerianus (KUNTZ) Exell methanol and aqueous leaf extracts. Arabian J Medic Aromatic Plants 5: 23-41.
  63. Lwanga GB (2017) Efficacy of the aqueous root extract of phyllanthus muellerianus in alleviating anemia in rats (Doctoral dissertation), The University of Zambia.
  64. Ajelara KO, Alafia AO, Denloye AA, Matanmi OS (2022) Comparative Repellency of Selected Plants to Adult Anopheles gambiea complex (Gilles) in the Laboratory. Ann Res Rev Biol 37: 18-24.
  65. Ada FB, Ayotunde EO. Sunday KI (2018) Haemo-immune system remediation potential of Phyllanthus muellerianus root extract in Clariasgariepinus exposed to 2, 4 Dimethyl Amine. Intern J Innov Environ Studies Res 6: 1-16.
  66. Ofokansi MN, Nworu CS, Akunne TC, Agbo MO, Akah PA (2018) Immunomodulatory effects of Phyllanthus muellerianus: A mechanistic approach. J Clin Cell Immunol 9: 2.
  67. Gnaléi RM, Bahi C, Gui PA et al. (2019) Phytochemical composition and cardioprotective activities of the total aqueous extract of Phyllanthus muellerianus leaves in diabetic rats. J Phytopharm 8: 203-9.
  68. Newman RA, Yang P, Pawlus AD, Block KI (2008) Cardiac glycosides as novel cancer therapeutic agents. Mol interv 8: 36.
  69. Shi J, Arunasalam K, Yeung D et al. (2004) Saponins from edible legumes: chemistry, processing, and health benefits. J Medic Foods 7: 67-78.
  70. Ofokansi MN, Ugwah-Oguejiofor CJ. Ihim S, Okoli CO Akah PA (2021) Neuropharmacological evaluation of the methanol leaf extract of Phyllanthus muellerianus (Kuntze) Exell and its ethyl acetate fraction in mice. Trop J Pharmaceu Res 20: 1463-72.
CommentsTable 1 CommentsTable 2
CommentsFigure 1